Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies

Vaccine and biotechnology names are leading a sharp sector rally, and a small protein-vaccine developer is posting the biggest gain of the group. Novavax (NASDAQ:NVAX) shares recently changed hands at $12.77, up 16%.